Symbols

NGEN

NervGen Pharma·NASDAQ

--(--)

NGEN Profile

Nervgen Pharma Corp.

Pioneer in Spinal Cord Injury Repair Therapy

Industry

Pharmaceutical

Established Date

01/19/2017

Listing Date

01/08/2026

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.nervgen.com

Security Type

Common stock

Office address

112-970 Burrard Street, Unit 1290, Vancouver, British Columbia, V6Z 2R4

Business

Introduction

NervGen Pharma Corp. was incorporated on January 19, 2017 under the Business Corporations Act (British Columbia). The company focuses on creating innovative solutions for the treatment of neurodegenerative and neurodegenerative diseases. The company is developing drugs to treat spinal cord injury, multiple sclerosis and Alzheimer's disease. The company is only engaged in a single business, namely drug research and development.